Registration gives the benefit of site update e-mails and additional information from Takeda on new education materials and events.
ADHD Institute Register

Meeting of Minds XIII
Now available on demand


Please register to view the speaker presentations and clinical hot topics from Meeting of Minds XIII,  9 – 25 November 2021
‘This meeting is initiated, organised and funded by Takeda’
For healthcare professionals only

Register now

ADHD can be a lifelong disorder


ADHD is a chronic neurodevelopmental disorder which can affect children, adolescents and adults

Read more

Assessment and diagnosis


ADHD assessment involves clinical examination, interviews and rating scales. Formal ADHD diagnosis typically utilises DSM-5TM or ICD-11 classification systems

Read more

Optimal management of ADHD


The optimal management of ADHD process should always consider input from the patient, family/caregivers and school to help establish an appropriate and extensive treatment programme (non-pharmacological and pharmacological therapy), goals and assessment/follow-up, resulting in a tailored multimodal treatment plan centred on the patient

Read more

Attention-deficit hyperactivity disorder (ADHD) is a diverse condition characterised by symptoms of inattention, hyperactivity and impulsivity; and can have a significant impact on patients’ lives.1,2 This website provides educational resources intended for healthcare professionals outside the US and UK with an interest in ADHD. It aims to share scientific advances in ADHD research and provide expert opinions and medical knowledge to support the healthcare professional community.

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 2013.
  2. World Health Organization. ICD-11: International Classification of Diseases 11th Revision. 2018. Available at: https://icd.who.int. Accessed January 2021.
Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Takeda has no influence or control over the content of this third party website.

Continue Cancel